Pharmafile Logo
Pharmafocus logo
Advanced Search

contraception

Showing 6 posts of 6 posts found.

FDA advisory committee votes in favour of OTC contraceptive pill

May 11, 2023
Medical Communications Contraception, FDA, OTC, Perrigo, contraception

Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …

News
iphone

First-ever approved fertility app more effective than the pill, experts say

February 13, 2017
Research and Development, Sales and Marketing contraception

Fertility app Natural Cycles has become the first-ever smartphone application and software solution to be approved by experts as a …

News
EMA offices, London

EMA starts contraceptive safety review

January 30, 2013
Manufacturing and Production, Sales and Marketing EMA, PRAC, VTE, contraception

Europe’s health regulator is to examine the safety of newer forms of contraceptive pills following concerns over potential health risks …

News

Bayer defends Yasmin against BMJ studies

April 26, 2011
Sales and Marketing Bayer, Yasmin, contraception

Bayer has rallied strongly behind its top-selling contraceptive brand Yasmin after two studies in the British Medical Journal questioned the …

News
FPA logo

Just teams up with sexual health charity

March 5, 2010
Medical Communications FPA, charity, contraception, just health pr

Just Health PR is providing PR support for the launch of a new UK consumer book on contraception from sexual …

News

Continuous dose contraceptive launched in US

July 30, 2007
Sales and Marketing contraception

Wyeth's Lybrel, the first ever contraceptive pill designed to be taken by women 365 days a year, has been launched …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024